Cardinal Health, Inc. (NYSE:CAH) Files An 8-K Other Events
Item8.01 Other Events
On June1, 2017, Cardinal Health, Inc. (Cardinal Health or the
Company) entered into an underwriting agreement (the Underwriting
Agreement) with Goldman, Sachs Co. LLC, Merrill Lynch, Pierce,
Fenner Smith Incorporated, MUFG Securities Americas Inc. and
Wells Fargo Securities, LLC as representatives of several
underwriters (the Underwriters) for the sale by the Company of
$1,000,000,000 aggregate principal amount of 1.948% Notes due
2019, $1,150,000,000 aggregate principal amount of 2.616% Notes
due 2022, $350,000,000 aggregate principal amount of Floating
Rate Notes due 2022, $750,000,000 aggregate principal amount of
3.079% Notes due 2024, $1,350,000,000 aggregate principal amount
of 3.410% Notes due 2027, and $600,000,000 aggregate principal
amount of 4.368% Notes due 2047 (collectively, the Notes). The
offering is being made to the Companys effective registration
statement on Form S-3 (Registration Statement No.333-215935)
previously filed with the Securities and Exchange Commission (the
Registration Statement). The Underwriting Agreement contemplates
that the Notes will be issued under an Indenture dated as of
June2, 2008 (the Indenture) between the Company and The Bank of
New York Mellon Trust Company, N.A., as trustee. A copy of the
Underwriting Agreement is filed as Exhibit 1.1 and is
incorporated herein by reference and as an exhibit to the
Registration Statement. The foregoing summary of the Underwriting
Agreement does not purport to be complete and is qualified in its
entirety by reference to the Underwriting Agreement.
In addition, on June1, 2017, the Company sent a notice of full
redemption to holders of its outstanding 1.700% Notes due 2018.
The 1.700% Notes due 2018 will be redeemed on July 1, 2017 at a
make-whole redemption price calculated in accordance with the
terms of such notes.
Item9.01 Financial Statements and Exhibits
| (d) | Exhibits |
|
Exhibit No. |
Description |
|
| 1.1 |
Underwriting Agreement, dated June1, 2017, among the Company, Goldman, Sachs Co. LLC, Merrill Lynch, Pierce, Fenner Smith Incorporated, MUFG Securities Americas Inc. and Wells Fargo Securities, LLC. |
About Cardinal Health, Inc. (NYSE:CAH)
Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and software to hospitals.